Odaia
107 employees on LinkedIn · 13 known investors
Find your way into Odaia
325 people in our graph share verified history with the Odaia team — schools, employers, funds. One of them is your warm intro.
ODAIA offers Marketing Intelligence, a platform for pharmaceutical marketing and sales teams that ties channel-level actions to prescription (Rx) outcomes and coordinates healthcare provider (HCP) engagement across digital and field channels. It uses attribution and sequencing engines to measure script lift and ROI per channel and recommend campaign messages and timing.
Also known as ODAIA · ODAIA Intelligence
Founders & leadership
Investors · 13
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMay 2023
Monograph Capital (lead), Threshold Ventures (lead), Alumni Ventures, BDC Capital, Flint Capital, Graphite Ventures, Innospark Ventures, MaRS IAF, Panache Ventures, StandUp Ventures, Wittington Ventures
Source ↗ - Undisclosed amountSeries AFeb 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026ODAIA develops a commercial intelligence platform for pharmaceutical companies that applies machine learning to customer and prescription data in order to identify unrealized prescription (Rx) opportunity, rank healthcare providers (HCPs) by channel, and coordinate omnichannel engagement. The company frames its approach as "customer science": combining a client's own data with observed customer behavior and ODAIA's AI models to produce a view of HCPs and their patient-level decisions.
The platform is organized into two products. ODAIA Field Intelligence provides sales representatives with AI-driven HCP prioritization, dynamic targeting and real-time engagement insights intended to support pre-call planning and territory decisions, including predictive views of NBRx and TRx trends. ODAIA Marketing Intelligence automates sequencing of individualized HCP campaigns, aligns field and digital teams on shared insights, and links touchpoints to prescription outcomes. Supporting content includes case-study material describing a pharma brand tracing 10,645 prescriptions back to specific campaign touchpoints across a universe of 70,000 physicians.
Business model
ODAIA sells software to pharmaceutical manufacturers, deploying its Field Intelligence and Marketing Intelligence products to commercial organizations that onboard individual brands onto the platform.
Traction
The company reports more than 40 brands onboarded, $53B in supported revenue, average incremental Rx lift of 7-14%, and a 14% increase in brand reach. Customer testimonials reference reduced pre-call planning time and identification of previously unprioritized high-potential prescribers.
Latest developments
ODAIA promotes on-demand content on HCP decision speed versus campaign cycles and a case study connecting campaign touchpoints to prescriptions, alongside its Field Intelligence and Marketing Intelligence product lines.
▸Full profile — market position, technology, go-to-market
Market position
ODAIA positions itself as a commercial intelligence platform purpose-built for pharma, contrasting its dynamic, behavior-based segmentation and channel-level prioritization with traditional static segmentation and reach-and-frequency approaches.
Technology
The platform uses machine learning and predictive analytics over client data and HCP behavioral data. Capabilities cited include explainable ML insights, dynamic segmentation in place of static targeting, HCP prioritization by channel, campaign sequencing, and predictive forecasting of NBRx and TRx trends for a client's molecule as well as competitor products, with one customer citing 96% accuracy.
Go-to-market
ODAIA markets through product demonstrations, on-demand webinars, case studies, and downloadable materials such as an "AI Blueprint for Pharma" and an AI readiness checklist aimed at commercial pharma leaders, with customer testimonials from sales representatives, account managers and marketing directors.
Pharmaceutical and biopharma commercial organizations — including field sales representatives, sales leadership, omnichannel and HCP experience marketing teams — ranging from large global manufacturers to midsize pharma organizations. Named or described users include GSK, Novo Nordisk, Acadia Pharmaceuticals, a top-25 pharma company, and a therapeutic dermatology group.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
In the news
▸Research sources · 1
primary sources listed
- Odaiaodaia.ai · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Odaia do?
- ODAIA builds an AI commercial intelligence platform that helps pharma field and marketing teams prioritize and engage HCPs.
- Who founded Odaia?
- Odaia was founded by Philip Poulidis.
- Who are Odaia's investors?
- Odaia's investors include Graphite Ventures, Monograph Capital Partners, Panache Ventures, Stand Up Ventures, Threshold Ventures, Toronto Innovation Acceleration Partners, Wittington Ventures, Alumni Ventures and 4 more.